Results 161 to 170 of about 3,935,952 (212)

Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes. [PDF]

open access: yesBlood Vessel Thromb Hemost
Eustes AS   +5 more
europepmc   +1 more source

Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies. [PDF]

open access: yesCancer Immunol Immunother
Takao S   +10 more
europepmc   +1 more source

TGF-β Receptor-dependent Tissue Factor Release and Proteomic Profiling of Extracellular Vesicles from Mechanically Compressed Human Bronchial Epithelial Cells. [PDF]

open access: yesAm J Respir Cell Mol Biol
Mwase C   +9 more
europepmc   +1 more source

Tissue Factor Pathway Inhibitor 2 Enhances Hepatocellular Carcinoma Chemosensitivity by Activating CCAR2-GADD45A-Mediated DNA Damage Repair. [PDF]

open access: yesInt J Biol Sci
Zhou H   +12 more
europepmc   +1 more source

Tissue Factor and COVID-19 Associated Thrombosis. [PDF]

open access: yesArterioscler Thromb Vasc Biol
Mackman N.
europepmc   +1 more source

Circulating, Extracellular Vesicle-Associated Tissue Factor in Cancer Patients with and without Venous Thromboembolism. [PDF]

open access: yesBiomolecules
Lami V   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy